Growth Metrics

Gyre Therapeutics (GYRE) FCF Margin Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5,389.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,525.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -341.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 43,511.00
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn 1,456.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,456.00
Dec 31, 2025 -578.00
Sep 30, 2025 881.00
Jun 30, 2025 3,454.00
Mar 31, 2025 -1,090.00
Dec 31, 2024 -1,348.00
Sep 30, 2024 -1,345.00
Jun 30, 2024 -3,456.00
Mar 31, 2024 -2,503.00
Dec 31, 2023 -3,786.00
Mar 31, 2023 155,243.00
Dec 31, 2022 76,610.00
Mar 31, 2022 14,263.00
Dec 31, 2021 36,440.00
Sep 30, 2021 51,756.00
Jun 30, 2021 -86,378.00
Mar 31, 2021 -163,089.00
Mar 31, 2018 -8.68 Mn
Dec 31, 2017 518,892.00
Sep 30, 2017 315,734.00
Jun 30, 2017 -40,889.00
Mar 31, 2017 284,907.00
Dec 31, 2016 -237,435.00
Sep 30, 2016 412,661.00
Jun 30, 2016 -339,774.00
Mar 31, 2016 -399,049.00
Dec 31, 2015 -450,094.00
Sep 30, 2015 -1.24 Mn
Jun 30, 2015 284,187.00
Mar 31, 2015 455,520.00
Dec 31, 2014 -2.53 Mn
Mar 31, 2014 -473,310.00
Dec 31, 2013 2.70 Mn
Mar 31, 2013 -15,641.00
Dec 31, 2012 -188,963.00
Sep 30, 2012 -125,842.00
Jun 30, 2012 6,139.00
Mar 31, 2012 -5,107.00
Dec 31, 2011 -3,067.00
Sep 30, 2011 1.25 Mn